Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y5KL
|
|||
| Former ID |
DIB010107
|
|||
| Drug Name |
RI-001
|
|||
| Synonyms |
RespImmune; RSV-IVIG; Respiratory syncytial virus infection therapy, ADMA Biologics
Click to Show/Hide
|
|||
| Indication | Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 2 | [1] | |
| Company |
Novavax
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00632463) RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.